MetLife Investment Management’s Pacific Biosciences PACB Stock Holding History

MetLife Investment Management’s Portfolio PACB Stock Details PACB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$206K	Buy	165,992 +22,561	+16%	+$28K	﹤0.01%	2175
2025 Q1	$169K	Sell	143,431 -1,948	-1%	-$2.3K	﹤0.01%	2285
2024 Q4	$266K	Buy	145,379 +25,216	+21%	+$46.1K	﹤0.01%	2152
2024 Q3	$204K	Sell	120,163 -33,996	-22%	-$57.8K	﹤0.01%	2278
2024 Q2	$211K	Buy	154,159 +32,858	+27%	+$45K	﹤0.01%	2208
2024 Q1	$455K	Sell	121,301 -10,494	-8%	-$39.4K	﹤0.01%	1729
2023 Q4	$1.29M	Hold	131,795	–	–	0.01%	1168
2023 Q3	$1.1M	Hold	131,795	–	–	0.01%	1179
2023 Q2	$1.75M	Buy	131,795 +1,753	+1%	+$23.3K	0.01%	986
2023 Q1	$1.51M	Buy	130,042 +12,183	+10%	+$141K	0.01%	1016
2022 Q4	$964K	Hold	117,859	–	–	0.01%	1229
2022 Q3	$684K	Hold	117,859	–	–	0.01%	1408
2022 Q2	$521K	Buy	117,859 +13,893	+13%	+$61.4K	﹤0.01%	1632
2022 Q1	$946K	Buy	103,966 +34,699	+50%	+$316K	0.01%	1366
2021 Q4	$1.42M	Hold	69,267	–	–	0.01%	982
2021 Q3	$1.77M	Hold	69,267	–	–	0.02%	915
2021 Q2	$2.42M	Buy	69,267 +2,554	+4%	+$89.3K	0.02%	790
2021 Q1	$2.22M	Sell	66,713 -5,088	-7%	-$169K	0.02%	825
2020 Q4	$1.86M	Hold	71,801	–	–	0.02%	863
2020 Q3	$709K	Buy	71,801 +6,448	+10%	+$63.6K	0.01%	1199
2020 Q2	$225K	Hold	65,353	–	–	﹤0.01%	1838
2020 Q1	$200K	Buy	65,353 +16,197	+33%	+$49.6K	﹤0.01%	1696
2019 Q4	$253K	Sell	49,156 -17,636	-26%	-$90.6K	﹤0.01%	1848
2019 Q3	$345K	Hold	66,792	–	–	﹤0.01%	1626
2019 Q2	$404K	Buy	66,792 +9,086	+16%	+$55K	﹤0.01%	1607
2019 Q1	$417K	Hold	57,706	–	–	﹤0.01%	1572
2018 Q4	$427K	Hold	57,706	–	–	0.01%	1463
2018 Q3	$312K	Sell	57,706 -1,041	-2%	-$5.63K	﹤0.01%	1834
2018 Q2	$209K	Hold	58,747	–	–	﹤0.01%	1901
2018 Q1	$120K	Buy	58,747 +45,502	+344%	+$92.9K	﹤0.01%	2129
2017 Q4	$35K	Buy	+13,245	New	+$35K	﹤0.01%	2217